This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With this award, Cellico will participate in the CES exhibition in Las Vegas, USA (January 9 ~ 12, 2024) for the second consecutive year. Cellico, by winning innovation awards for two consecutive years and, unusually, in three categories at CES 2024, has once again validated its excellent technological capabilities.
To help startups attract foreign investment, the Gyeonggi Provincial Office plans to hold an international investment fair for startups in Pangyo in the second half of 2024. In addition, large companies in the 2nd Pangyo Techno Valley are supporting startup companies with more than 200 programs.
Cellico’s technology has been recognized globally by winning the Innovation Award at CES, the largest electronics trade show in the United States, in 2023 and 2024. Cellico is developing a product to help patients with these diseases see in place of damaged photoreceptor cells. Rebellions, Inc.
Construction is expected to be completed by the end of 2024, and 300 billion won will be invested to make it 10 stories above ground and 4 stories underground, with a total floor area of 66,115 m2. CGB is the world’s largest cell therapy and gene therapy development facility. We’re here to facilitate valuable partnerships.
We organize all of the trending information in your field so you don't have to. Join 24,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content